STAT3 regulates antiviral immunity by suppressing excessive interferon signaling

Cell Rep. 2023 Jul 25;42(7):112806. doi: 10.1016/j.celrep.2023.112806. Epub 2023 Jul 11.

Abstract

This study identifies interleukin-6 (IL-6)-independent phosphorylation of STAT3 Y705 at the early stage of infection with several viruses, including influenza A virus (IAV). Such activation of STAT3 is dependent on the retinoic acid-induced gene I/mitochondrial antiviral-signaling protein/spleen tyrosine kinase (RIG-I/MAVS/Syk) axis and critical for antiviral immunity. We generate STAT3Y705F/+ knockin mice that display a remarkably suppressed antiviral response to IAV infection, as evidenced by impaired expression of several antiviral genes, severe lung tissue injury, and poor survival compared with wild-type animals. Mechanistically, STAT3 Y705 phosphorylation restrains IAV pathogenesis by repressing excessive production of interferons (IFNs). Blocking phosphorylation significantly augments the expression of type I and III IFNs, potentiating the virulence of IAV in mice. Importantly, knockout of IFNAR1 or IFNLR1 in STAT3Y705F/+ mice protects the animals from lung injury and reduces viral load. The results indicate that activation of STAT3 by Y705 phosphorylation is vital for establishment of effective antiviral immunity by suppressing excessive IFN signaling induced by viral infection.

Keywords: CP: Immunology; IL-6; MAVS; RIG-I; STAT3; influenza A virus; innate immunity; interferon.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents
  • Immunity, Innate
  • Influenza A virus*
  • Interferons
  • Mice
  • Orthomyxoviridae Infections* / immunology
  • Receptors, Interferon
  • STAT3 Transcription Factor* / immunology
  • Signal Transduction

Substances

  • Antiviral Agents
  • IFNLR1 protein, mouse
  • Interferons
  • Receptors, Interferon
  • Stat3 protein, mouse
  • STAT3 Transcription Factor